Find a Pharmacy
Vertice Login
Info banner
A significant part of the Healthesystems vision is to create a more integrated experience for our customers

Advocacy & Compliance

Healthesystems’ Advocacy & Compliance experts are essential in the management of pharmacy and ancillary benefits for our clients. By tracking and influencing regulatory activity, our team stays  ahead of evolving trends and identifies opportunities to advocate on behalf of our clients, their injured workers, and the broader industry.

The Advocacy & 
Compliance Team

Monitors and reports on proposed and pending regulatory changes that impact workers' comp, helping shape effective program strategies

Advocates for fair and balanced public policy through proactive engagement with regulators, customers, and other stakeholders throughout the rulemaking lifecycle

Supports operational compliance by providing guidance to internal stakeholders and external partners during the implementation of new regulatory changes

Regulatory Recap

A weekly e-newsletter informed by the Advocacy & Compliance team to help keep our clients and industry contacts in the know on the latest legislation and policy updates impacting workers’ comp.
Subscribe

California Reports on Cumulative Trauma Claims

California's rate of permanent partial disability claims reached approximately three times the national median.
Read More →
July 27, 2026

IAIABC to Host PBM Legislation Webinar

The August 20th webinar will discuss the impact of PBM legislation on workers' compensation systems.
Read More →
July 27, 2026

NCCI Explores Workers’ Comp Trends by Industry and State

While most industries saw declines in claim frequency, healthcare, office, and private education defied larger trends.
Read More →
July 27, 2026

FDA Seeks Input on Potential Therapeutic Use of Psychedelic Drugs

A public hearing will be held on September 14th. with written comments accepted until October 5th.
Read More →
July 20, 2026

Connecticut Reduces Drug Reimbursement Rates

Updates to the Practitioner Fee Schedule switch from an AWP-plus reimbursement model to an AWP-discount model.
Read More →
July 20, 2026

California P&T Committee Reviews Rising Drug Costs and Utilization Patterns

The Committee is focused on high-cost and high-utilization medications, including GLP-1s, PPIs, anticonvulsants, topical agents, and biologics.
Read More →
July 20, 2026

Florida’s Physician Dispensing Rules Continue to Be Evaluated

Commenters asked the DWC to clarify the scope of pharmacy and pharmacist definitions and prior authorization requirements.
Read More →
July 20, 2026

SAWCA Convention Recap

Access to care and AI emerged as dominant themes of the conference.
Read More →
July 20, 2026

Alaska Revises Cancer Presumption for Firefighters

While cancer coverage remains the same, timelines and qualifications for coverage have been adjusted.
Read More →
July 20, 2026

Subscribe to Regulatory Recap

Get weekly legislation & policy updates straight to your inbox.
regulatory recap newsletter image
hello world!

 Further resources you may be interested in

Additional articles and updates from Healthesystems related to policy shaping workers’ comp.

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduce significant implications for clinical research, drug development, and downstream utilization.
Read More

White House Issues Executive Order on Psychedelics

The order seeks to accelerate clinical trials, data sharing, drug approvals, and possibly rescheduling.
Read More

Texas Approves Audit of Topical Analgesics

After soliciting stakeholder feedback on possible audit topics, the DWC prioritized a study of topical analgesics by the Medical Quality Review Panel.
Read More

Rescheduling Questions: How the Marijuana Landscape Could Soon Change

The rescheduling of marijuana may introduced significant implications for clinical research, drug development, and downstream utilization.
Read More

State of the Nation: Summer 2026

Healthesystems’ Sandy Shtab examines key workers’ comp policy trends, from PBM regulation and AI oversight to marijuana rescheduling and injured worker engagement.
Read More

Pennsylvania Proposes Reimbursement Caps for Compounds and Topicals

The bill would create a $400, 30-day supply cap for compound drugs.
Read More
Back to Top
lockmap-markermagnifiercrossmenuarrow-rightcross-circle